ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,985.38
      0.02%
      US Tech 100
      20,497.20
      0.04%
      Dow Jones
      43,958.19
      0.11%
      Brent Oil
      72.295
      0.60%
      Bitcoin
      90,855.46
      0.32%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU

      6. Genfit (GNFT) Quote

      Genfit

      Genfit (GNFT)

      Genfit SA
      4.225
      -0.66
      ( -13.51% )
      Updated: 05:56:07
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      4.225
      Bid
      4.22
      Ask
      4.24
      Volume
      608,168
      4.135 Day's Range 4.955
      2.90 52 Week Range 5.86
      Market Cap
      210.553M
      Previous Close
      4.885
      Open
      4.89
      Last Trade
      140
      @
      4.225
      Last Trade Time
      05:56:39
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      304,697
      Shares Outstanding
      49,834,983
      Dividend Yield
      -
      PE Ratio
      -7.31
      Earnings Per Share (EPS)
      -0.58
      Revenue
      38.68M
      Net Profit
      -28.89M

      About Genfit

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.genfit.com
      Headquarters
      Loos, Nord, Fra
      Founded
      -
      Genfit is listed in the Pharmaceutical Preparations sector of the Euronext with ticker GNFT. The last closing price for Genfit was 4.89 €. Over the last year, Genfit shares have traded in a share price range of 2.90 € to 5.86 €.

      Genfit currently has 49,834,983 shares outstanding. The market capitalization of Genfit is 243.44 € million. Genfit has a price to earnings ratio (PE ratio) of -7.31.

      Ask ADVFN Intelligence (AI)

      GNFT Latest News

      More News

      GENFIT fait un point d’actualité sur ses activités à l’occasion de sa participation prochaine à l’AASLD Liver Meeting® 2024

      GENFIT fait un point d’actualité sur ses activités à l’occasion de sa participation prochaine à l’AASLD Liver Meeting® 2024 Programme PBC (sous licence Ipsen) : Ipsen présentera de nouvelles...

      14 hours ago
      UK Regulatory

      GENFIT Announces Corporate Updates and Upcoming Participation at The Liver Meeting® 2024

      GENFIT Announces Corporate Updates and Upcoming Participation at The Liver Meeting® 2024 PBC program (licensed to Ipsen): Ipsen to present new data on elafibranor at The Liver Meeting® 2024Launch...

      14 hours ago
      UK Regulatory

      GENFIT Announces Corporate Updates and Upcoming Participation at The Liver Meeting® 2024

      PBC program (licensed to Ipsen): Ipsen to present new data on elafibranor at The Liver Meeting® 2024Launch of Iqirvo® (elafibranor)1 on track with expectations; encouraging feedback from...

      14 hours ago
      GlobeNewswire Inc.

      GENFIT : Information financière du troisième trimestre 2024

      GENFIT : Information financière du troisième trimestre 2024 Trésorerie et équivalents de trésorerie s’élevant à 96,0 millions d’euros au 30 septembre 202459,7 millions d’euros de revenus des neuf...

      November 07 2024
      UK Regulatory

      GENFIT Reports Third Quarter 2024 Financial Information

      GENFIT Reports Third Quarter 2024 Financial Information Cash and cash equivalents totaled €96.0 million as of September 30, 2024€59.7 million in revenues for the nine months ended September 30...

      November 07 2024
      UK Regulatory

      GENFIT Reports Third Quarter 2024 Financial Information

      Cash and cash equivalents totaled €96.0 million as of September 30, 2024€59.7 million in revenues for the nine months ended September 30, 2024, including the €48.7 million milestone invoiced in...

      November 07 2024
      GlobeNewswire Inc.

      GENFIT: Ipsen’s Iqirvo® (Elafibranor) Receives EU Approval as a First-in-Class Treatment for Primary Biliary Cholangitis following U.S. FDA Accelerated Approval

      GENFIT: Ipsen’s Iqirvo® (Elafibranor) Receives EU Approval as a First-in-Class Treatment for Primary Biliary Cholangitis following U.S. FDA Accelerated Approval Lille (France), Cambridge...

      September 23 2024
      UK Regulatory

      GENFIT : Iqirvo® d’Ipsen (elafibranor) reçoit l’approbation UE en tant que traitement first-in-class de la Cholangite Biliaire Primitive consécutivement à l’approbation accélérée de la FDA américaine

      GENFIT : Iqirvo® d’Ipsen (elafibranor) reçoit l’approbation UE en tant que traitement first-in-class de la Cholangite Biliaire Primitive consécutivement à l’approbation accélérée de la FDA...

      September 23 2024
      UK Regulatory

      GENFIT: Ipsen’s Iqirvo® (Elafibranor) Receives EU Approval as a First-in-Class Treatment for Primary Biliary Cholangitis following U.S. FDA Accelerated Approval

      Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), September 23, 2024 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to...

      September 23 2024
      GlobeNewswire Inc.

      GENFIT : Résultats financiers du premier semestre 2024 et point sur les activités de la Société

      GENFIT : Résultats financiers du premier semestre 2024 et point sur les activités de la Société Trésorerie et équivalents de trésorerie s’élevant à 61,6 millions d’euros au 30 juin 2024 n’incluant...

      September 19 2024
      UK Regulatory
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-1.135-21.17537313435.365.474.1353424834.93118538DE
      4-1.445-25.48500881835.675.864.1353134535.22171602DE
      120.2255.62545.863.6253046974.93221887DE
      260.8324.44771723123.3955.863.333287014.59891866DE
      520.9127.45098039223.3155.862.92637804.17355589DE
      1561.07734.21219822113.1485.862.7462128693.93362829DE
      260-9.875-70.035460992914.120.962.7463077615.62876332DE

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      ALCYBCybergun
      0.0002 €
      (100.00%)
      		2.46M
      ALNEVNeovacs
      0.0003 €
      (50.00%)
      		7.3M
      MLUMGUmalis Group
      1.89 €
      (18.13%)
      		1.71k
      ALRPDRapid Nutrition
      0.0692 €
      (15.33%)
      		7.39M
      MLLOILocasystem International
      14.00 €
      (12.90%)
      		10
      MLACTActivium Group
      1.39 €
      (-32.52%)
      		1.05k
      ATOAtos SE
      0.21 €
      (-29.55%)
      		4.33M
      ATODSAtos SE
      0.0216 €
      (-28.48%)
      		2.36M
      EBUSREbusco
      0.37 €
      (-19.57%)
      		343.14k
      VACBSPierre & Vacances
      0.042 €
      (-16.00%)
      		122.95k
      BCPBanco Comercial Portugues SA
      0.44 €
      (-0.05%)
      		11.19M
      ALTDTonner Drones
      0.0106 €
      (3.92%)
      		9.9M
      ALDRVDrone Volt
      0.0036 €
      (-2.70%)
      		7.73M
      ALRPDRapid Nutrition
      0.0692 €
      (15.33%)
      		7.39M
      ALNEVNeovacs
      0.0003 €
      (50.00%)
      		7.3M

      Discussion

      View Full Feed
      tenac tenac 4 minutes ago
      O Lord, you are my God; I will exalt you; I will praise your name, for you have done wonderful things, plans formed of old, faithful and sure.
      Isaiah 25:1
      tenac tenac 4 minutes ago
      O Lord, you are my God; I will exalt you; I will praise your name, for you have done wonderful things, plans formed of old, faithful and sure.
      Isaiah 25:1
      walterc walterc 5 minutes ago
      I agree on that one.

      MZ resignation is long overdue.

      But business success is the primary trigger. .
      Timelines are a problem on all my investments. i am used to that.
      LWLG
      StayHumble StayHumble 6 minutes ago
      Power2 the P1ayers!✅24/7 interest here✅2 !nfinity! & beyond
      GME
      Atlanta1 Atlanta1 7 minutes ago
      despite claims to the contrary, SINT has exited the armor business:

      In the third quarter of 2024, the Company made difficult, but essential, decisions to align with its renewed focus. Notably, SINTX made the decision to cease operations of its armor division and recorded a one-time $4
      SINT
      oldstocks oldstocks 7 minutes ago
      Relocating and Expanding Factory to Address Accelerating Demand for AI-Enabled Technologies

      That is what i noticed on the one company moving from the otc to nasdaq
      Last year it was 27 cents now $11.32

      If people stop trashing OneMind Technologies parent company AF
      AFFU
      tenac tenac 8 minutes ago
      “For thus says the Lord God: Behold, I, I myself will search for my sheep and will seek them out. As a shepherd seeks out his flock when he is among his sheep that have been scattered, so will I seek out my sheep, and I will rescue them from all places where they have been scattered on a day of clou
      DAR53 DAR53 8 minutes ago
      north40000, as always, thanks for your insight into the legal side of Amarin. Is there anything that can be done to bring more awareness to the FTC, SEC and DOJ to hopefully get the Nevada trial reversed? Let us know and I'm sure we could send a barage of emails to gain attention to this grevious
      AMRN
      tenac tenac 8 minutes ago
      “For thus says the Lord God: Behold, I, I myself will search for my sheep and will seek them out. As a shepherd seeks out his flock when he is among his sheep that have been scattered, so will I seek out my sheep, and I will rescue them from all places where they have been scattered on a day of clou
      tenac tenac 9 minutes ago
      The salvation of the righteous is from the Lord; he is their stronghold in the time of trouble.
      Psalm 37:39
      tenac tenac 9 minutes ago
      The salvation of the righteous is from the Lord; he is their stronghold in the time of trouble.
      Psalm 37:39
      EZ2 EZ2 9 minutes ago
      HOOSIERS ROCK !!!!
      tenac tenac 9 minutes ago
      The Lord is not slow to fulfill his promise as some count slowness, but is patient toward you, not wishing that any should perish, but that all should reach repentance.
      2 Peter 3:9
      tenac tenac 9 minutes ago
      The Lord is not slow to fulfill his promise as some count slowness, but is patient toward you, not wishing that any should perish, but that all should reach repentance.
      2 Peter 3:9
      sctts sctts 9 minutes ago
      $$$ Today is the Day $$$$

      $$$$ $FRX $$$$
      FRX
      EZ2 EZ2 10 minutes ago
      Nailed it Cap ~~~~ on another board. I was NOT enthralled with the THUNE vote..... we'll see ! :-?
      researcher59 researcher59 11 minutes ago
      Those returns are hard to believe since it's a hedge fund not open to the public, but maybe it's true ? Also the larger the amount of money the more difficult it becomes to generate outsized return. Not enough liquidity to support constant trading of $100B even in the megacaps. No doubt he's had
      rikkie rikkie 12 minutes ago
      Mine neither, but better communication would be nice!
      LWLG
      uplata uplata 12 minutes ago
      What do you mean with me..
      Matt24777 Matt24777 12 minutes ago
      You are welcome, RSI38.

      EXTREMELY BULLISH 
      PLYZ
      Money hunt Money hunt 13 minutes ago
      Full power blue skies up ahead dudes…
      ELAB

      Your Recent History

      EU
      GNFT
      Genfit
      TG
      SQZ
      SEACOR Marine
      NYSE
      SGM
      STONEGATE MORTGAGE CORP
      Delayed Upgrade Clock